109 related articles for article (PubMed ID: 6135061)
1. TSH and orbital antibodies.
Waring S; Kodama K; Sikorska H; Wall JR
Lancet; 1983 Jul; 2(8343):224-5. PubMed ID: 6135061
[No Abstract] [Full Text] [Related]
2. Autoantibodies to eye muscle and orbital fibroblasts in the pathogenesis of thyroid-associated ophthalmopathy.
Weightman D; Perros P; Sherif I; Janat F; Kendall-Taylor P
Exp Clin Endocrinol; 1991 May; 97(2-3):197-201. PubMed ID: 1915634
[No Abstract] [Full Text] [Related]
3. Affinity purification of orbital membrane antigens for the study of the pathogenesis of Graves' ophthalmopathy.
Salvi M; Bingoye F; Chung F; Wall JR
J Clin Endocrinol Metab; 1988 May; 66(5):939-45. PubMed ID: 3360902
[TBL] [Abstract][Full Text] [Related]
4. [Pathogenesis of diffuse toxic goiter].
Neĭmark II; Kalinin AP
Sov Med; 1991; (8):37-40. PubMed ID: 1763358
[No Abstract] [Full Text] [Related]
5. Demonstration of thyrotropin receptor mRNA in orbital fat and eye muscle tissues from patients with Graves' ophthalmopathy by in situ hybridization.
Wu SL; Yang CS; Wang HJ; Liao CL; Chang TJ; Chang TC
J Endocrinol Invest; 1999 Apr; 22(4):289-95. PubMed ID: 10342363
[TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy.
Wall JR; Henderson J; Strakosch CR; Joyner DM
Can Med Assoc J; 1981 Apr; 124(7):855-62, 866. PubMed ID: 7011529
[TBL] [Abstract][Full Text] [Related]
7. [Structure of receptors and expression of anti-receptor antibodies. c. Anti-TSH receptor antibodies].
Izumi M; Nagataki S
Nihon Rinsho; 1988 Apr; 46(4):822-8. PubMed ID: 3404704
[No Abstract] [Full Text] [Related]
8. Graves' ophthalmopathy and the TSH receptor.
Franklyn JA
Lancet; 1993 Aug; 342(8867):318-9. PubMed ID: 8101579
[No Abstract] [Full Text] [Related]
9. Soluble ecto-domain mutant of thyrotropin (TSH) receptor incapable of binding TSH neutralizes the action of thyroid-stimulating antibodies from Graves' patients.
Osuga Y; Liang SG; Dallas JS; Wang C; Hsueh AJ
Endocrinology; 1998 Feb; 139(2):671-6. PubMed ID: 9449640
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy.
Jyonouchi SC; Valyasevi RW; Harteneck DA; Dutton CM; Bahn RS
Thyroid; 2001 Oct; 11(10):929-34. PubMed ID: 11716039
[TBL] [Abstract][Full Text] [Related]
11. Antithyroglobulin monoclonal and autoantibodies cross-react with an orbital connective tissue membrane antigen: a possible mechanism for the association of ophthalmopathy with autoimmune thyroid disorders.
Kuroki T; Ruf J; Whelan L; Miller A; Wall JR
Clin Exp Immunol; 1985 Nov; 62(2):361-70. PubMed ID: 3841305
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to the thyrotropin receptor raised by an autoantiidiotypic protocol and their relationship to monoclonal autoantibodies from Graves' patients.
Hill BL; Erlanger BF
Endocrinology; 1988 Jun; 122(6):2840-50. PubMed ID: 2453350
[TBL] [Abstract][Full Text] [Related]
13. Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.
Costagliola S; Many MC; Denef JF; Pohlenz J; Refetoff S; Vassart G
J Clin Invest; 2000 Mar; 105(6):803-11. PubMed ID: 10727449
[TBL] [Abstract][Full Text] [Related]
14. Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy.
Bahn RS
Thyroid; 2002 Mar; 12(3):193-5. PubMed ID: 11952038
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of a monoclonal antibody to the thyrotropin receptor that acts as a powerful thyroid-stimulating autoantibody antagonist.
Sanders J; Allen F; Jeffreys J; Bolton J; Richards T; Depraetere H; Nakatake N; Evans M; Kiddie A; Premawardhana LD; Chirgadze DY; Miguel RN; Blundell TL; Furmaniak J; Smith BR
Thyroid; 2005 Jul; 15(7):672-82. PubMed ID: 16053383
[TBL] [Abstract][Full Text] [Related]
16. Eye-muscle membrane antibodies in autoimmune orbitopathy.
Nauman J; Adler G; Faryna M
Exp Clin Endocrinol; 1991 May; 97(2-3):202-5. PubMed ID: 1915635
[No Abstract] [Full Text] [Related]
17. [The role of antibodies in Graves' ophthalmopathy].
Molnár I; Balázs C
Orv Hetil; 1991 Sep; 132(38):2097-100. PubMed ID: 1923482
[TBL] [Abstract][Full Text] [Related]
18. Antibody-dependent cell-mediated cytotoxicity against orbital target cells in thyroid-associated ophthalmopathy and related disorders; close relationship between serum cytotoxic antibodies and parameters of eye muscle dysfunction.
Barsouk A; Peele KA; Kiljanski J; Stolarski C; Nebes V; Kennerdell JS; Volpe R; Wall JR
J Endocrinol Invest; 1996 Jun; 19(6):334-41. PubMed ID: 8844451
[TBL] [Abstract][Full Text] [Related]
19. [Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach].
Akamizu T; Kosugi S; Kohn LD; Mori T
Nihon Rinsho; 1994 Apr; 52(4):1024-30. PubMed ID: 7515117
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and significance of antibodies reactive with eye muscle membrane antigens in sera from patients with Graves' ophthalmopathy and other thyroid and nonthyroid diseases.
Wu YJ; Clarke EM; Shepherd P
Thyroid; 1998 Feb; 8(2):167-74. PubMed ID: 9510126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
